| Bioactivity | CDK9-IN-29 (compound Z11) is a potent CDK9 inhibitor (IC50 = 3.20 nM) with good kinase selectivity. CDK9-IN-29 inhibits cell proliferation and induces apoptosis[1]. |
| Name | CDK9-IN-29 |
| CAS | 2737262-24-5 |
| Formula | C29H33F2N5O4 |
| Molar Mass | 553.60 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Tizhi Wu, et al. Discovery of Selective and Potent Macrocyclic CDK9 Inhibitors for the Treatment of Osimertinib-Resistant Non-Small-Cell Lung Cancer. J Med Chem. 2023. |
CDK9-IN-29
CAS: 2737262-24-5 F: C29H33F2N5O4 W: 553.60
CDK9-IN-29 (compound Z11) is a potent CDK9 inhibitor (IC50 = 3.20 nM) with good kinase selectivity. CDK9-IN-29 inhibits
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.